Immune to Cancer: The CRI Blog
-
Esophageal Cancer Awareness Month: 2022 Immunotherapy Research Updates
This April for Esophageal Cancer Awareness Month, discover the new research, new treatments, and progress for a…
-
Esophageal Cancer Awareness Month: 2021 Immunotherapy Research Updates
This April for Esophageal Cancer Awareness Month, we look at new research, new treatments, and how we’re…
-
Esophageal Cancer Awareness Month: 2020 Immunotherapy Research Update
Promising new research, a variety of immunotherapy treatment combinations, and how we’re working toward a future immune…
-
How Immunotherapy for Esophageal Cancer is Making an Impact
Dr. Deirdre Cohen discusses recent advances in immunotherapy for esophageal cancer, including biomarkers, checkpoint inhibitors, cell-based therapies,…
-
Checkpoint Immunotherapy Approved for Patients with Stomach, Gastroesophageal, and Liver Cancer
Previously treated patients with these cancer types can now receive anti-PD-1 immunotherapy; nivolumab for HCC and pembrolizumab…
-
Jon Deisher’s Immunotherapy Story
Esophageal Cancer | Diagnosed 2013 Jon’s Story Jon Deisher is a life-long Alaskan who has devoted himself to…